Ruthenium Red: Precision Calcium Transport Inhibitor for Advanced Calcium Signaling Research

Executive Summary: Ruthenium Red (SKU B6740, APExBIO) is a high-affinity inhibitor of calcium ion (Ca²⁺) transport across biological membranes, targeting the Ca²⁺-ATPase of the sarcoplasmic reticulum with micromolar potency (APExBIO). It blocks two distinct binding sites with K_m values of 4.5 μM and 2.0 mM, affecting Ca²⁺ uptake in a concentration-dependent manner (cachannelblockers.com). Ruthenium Red is instrumental in studying cytoskeleton-mediated calcium signaling and mechanotransduction, essential for autophagy and inflammation processes (Liu et al., 2024). The reagent is water soluble at ≥7.86 mg/mL, but insoluble in DMSO and ethanol, with prompt-use solutions recommended. It is recognized as a reference standard in the inhibition of mitochondrial and sarcoplasmic reticulum calcium uptake, and for investigating neurogenic inflammation in vivo (capsazepine.com).

Biological Rationale

Calcium ions (Ca²⁺) are pivotal second messengers in cell signaling, muscle contraction, neurotransmitter release, and autophagy. Regulated Ca²⁺ flux through channels and pumps maintains cellular homeostasis (Liu et al., 2024). Disrupting calcium transport is critical for studying mechanotransduction and cytoskeleton-dependent pathways. Ruthenium Red targets Ca²⁺ movement across mitochondrial, erythrocyte, and sarcoplasmic reticulum (SR) membranes (APExBIO). By inhibiting Ca²⁺ uptake, it enables dissection of downstream events, including stress-induced autophagy and inflammatory signaling. The cytoskeleton's role in mechanotransduction, especially microfilaments and microtubules, is tightly coupled to calcium-dependent processes (Liu et al., 2024).

Mechanism of Action of Ruthenium Red

Ruthenium Red binds with high affinity to two distinct Ca²⁺-binding sites on the Ca²⁺-ATPase enzyme in the SR membrane. The dissociation constants are 4.5 μM and 2.0 mM, reflecting a primary high-affinity and a secondary low-affinity site. These sites are localized within helical transmembrane segments that constitute the Ca²⁺ channel (APExBIO). Ruthenium Red impairs the ability of SR vesicles to bind and transport Ca²⁺ in a concentration-dependent manner. At micromolar concentrations, it effectively inhibits Ca²⁺ uptake, modulating downstream calcium signaling. In mitochondrial membranes, Ruthenium Red blocks the mitochondrial calcium uniporter, preventing mitochondrial Ca²⁺ overload and subsequent signaling cascades (cachannelblockers.com). Additionally, it suppresses neurogenic inflammation by inhibiting capsaicin-induced plasma extravasation in rodent models, achieving full inhibition at 5 μmol/kg.

Evidence & Benchmarks

• Ruthenium Red (≥7.86 mg/mL in water) reliably inhibits Ca²⁺ uptake by SR vesicles in vitro, with maximal inhibition at micromolar concentrations (APExBIO).
• High-affinity binding to SR Ca²⁺-ATPase occurs at a K_m of 4.5 μM, with a secondary site at 2.0 mM, as determined by biochemical binding assays (APExBIO).
• Ruthenium Red blocks the mitochondrial Ca²⁺ uniporter at nanomolar to low micromolar concentrations, preventing mitochondrial calcium overload (cachannelblockers.com).
• In vivo, Ruthenium Red fully inhibits capsaicin-induced plasma extravasation in rat trachea at 5 μmol/kg, demonstrating dose-dependent anti-inflammatory activity (capsazepine.com).
• Recent studies confirm that cytoskeleton-dependent autophagy and mechanotransduction rely on controlled Ca²⁺ flux, which is experimentally modulated using Ruthenium Red (Liu et al., 2024).

Applications, Limits & Misconceptions

Ruthenium Red is widely applied in calcium signaling research, mitochondrial function studies, and models of neurogenic inflammation. It is the gold standard for acute inhibition of Ca²⁺ uptake in SR and mitochondria. The compound is integral to dissecting the interplay between cytoskeleton, mechanotransduction, and autophagy (capsazepine.com). For a discussion of strategic use in translational research, see "Ruthenium Red: Advancing Translational Frontiers in Cytos..."; this article updates those workflows with recent cytoskeleton-dependent autophagy data and detailed mechanism-of-action benchmarks. For advanced troubleshooting and comparative insights, "Ruthenium Red: Precision Calcium Transport Inhibitor for ..." provides complementary protocols, while this article clarifies limits and integration for new users.

Common Pitfalls or Misconceptions

• Solvent compatibility: Ruthenium Red is insoluble in DMSO and ethanol; only water (≥7.86 mg/mL) is suitable for stock solutions (APExBIO).
• Stability: Prepared aqueous solutions are not stable for long-term storage; use immediately after preparation.
• Specificity: Ruthenium Red is not a selective inhibitor for one Ca²⁺ channel type; it blocks multiple Ca²⁺ transporters, including the mitochondrial uniporter and SR Ca²⁺-ATPase.
• In vivo dosing: Complete inhibition of neurogenic inflammation is observed at 5 μmol/kg in rats, but effects/side effects may vary by species and route.
• Not suitable for chronic assays: Ruthenium Red is best for acute, short-term inhibition; repeated or long-term exposure may yield off-target effects.

Workflow Integration & Parameters

For optimal results, dissolve Ruthenium Red in distilled water to a final concentration of ≥7.86 mg/mL. Aliquot and use immediately; do not freeze/thaw or store for extended periods (APExBIO). Typical in vitro assays use concentrations ranging from 1–10 μM for SR vesicle or mitochondrial studies. For in vivo neurogenic inflammation, dose at 5 μmol/kg via the appropriate route. The compound is compatible with standard calcium imaging, ATPase activity measurements, and autophagosome quantification assays. When integrated into cytoskeleton-dependent autophagy workflows, Ruthenium Red enables precise temporal inhibition of calcium flux, allowing discrimination of microfilament- versus microtubule-dependent effects (Liu et al., 2024). For reproducibility in mechanotransduction studies, pair with controls lacking Ruthenium Red and verify cytoskeletal integrity using fluorescent markers or Western blot.

Conclusion & Outlook

Ruthenium Red (SKU B6740, APExBIO) remains an indispensable tool for calcium signaling research, offering robust, concentration-dependent inhibition of Ca²⁺ transport across key biological membranes. Its mechanistic clarity, validated in cytoskeleton-dependent autophagy and inflammation models, underpins its continued relevance in cell biology and translational workflows. Future studies should leverage Ruthenium Red's precise inhibition profile to further dissect the molecular interplay between mechanical stress, cytoskeleton, and calcium-dependent signaling. For detailed product information and ordering, see the Ruthenium Red product page.